Back to Search
PARKER COLE, MD
MD
Family Medicine Physician
NPI: 1083101497IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2018
Research & Publications (20)
Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
PMID 17768625·Cancer Chemother Pharmacol·2008
3-trial
Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia.
PMID 17061283·Ment Retard Dev Disabil Res Rev·2006
6-review
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
PMID 12172974·Cancer Chemother Pharmacol·2002
7-preclinical
Effects of overexpression of gamma-Glutamyl hydrolase on methotrexate metabolism and resistance.
PMID 11389096·Cancer Res·2001
8-other
Fine-Lubinsky syndrome: managing the rare syndromic synostosis.
PMID 19251507·J Plast Reconstr Aesthet Surg·2010
5-case
Protein phosphorylation by semisynthesis: from paper to practice.
PMID 19632467·Methods Enzymol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3555 OLENTANGY RIVER RD STE 1080
COLUMBUS, OH 43214 - Phone
- (614) 268-8164
Quick Facts
- NPI
- 1083101497
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile